Has Suketu Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,424 in general payments to Suketu Patel, MD across 23 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Suketu Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Suketu Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Suketu Patel, MD

Radiation Oncology · Perrysburg, OHNPI 1912326877

Payments from drug & device makers

$2,424in general payments, 2019–2025

Across 23 payments — averaging $105.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$885
AstraZeneca$609
Merck$176
Blue Earth Diagnostics$176
Bayer$122
Novocure Inc.$121
plus $336 from 6 others

What the payments were for

Consulting fees$52522%
Speaking & faculty fees$422%
Travel & lodging$78332%
Food & beverage$1,07444%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	7	$885
AstraZeneca	2	$609
Merck	2	$176
Blue Earth Diagnostics	2	$176
Bayer	1	$122
Novocure Inc.	1	$121
Tactile Systems Technology Inc	2	$118
E.r. Squibb & Sons, L.L.C.	1	$89
Amgen	2	$49
BD	1	$42
Xeris Pharmaceuticals, Inc.	1	$20
Astellas Pharma US Inc	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,424 in reported general payments places this provider in the 75th percentile of 255 radiation oncology providers in Ohio.

See all radiation oncology providers in Ohio →

Medicare billing

Part B allowed, 2024

$151,248

Medicare patients

200

Services billed

1,608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Betamethasone Valerate	33	$908
Tamsulosin Hcl	67	$829
Lidocaine Hcl ViscousLidocaine Hcl	13	$280
Fluconazole	15	$188
Oxybutynin Chloride ErOxybutynin Chloride	13	$163
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	11	$121
Levothyroxine Sodium	16	$80
Dexamethasone	13	$73

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Perrysburg

Shlomo KoyfmanCleveland$2.4M
Arnab ChakravartiColumbus$1.4M
Angela Yuanyuan JiaCleveland$1M
Daniel SprattCleveland$834K
Steven KurtzmanGarfield Heights$833K
Jeremy BrownsteinColumbus$522K
Sasha BeyerColumbus$504K
John BrenemanCincinnati$503K
Joshua PalmerColumbus$453K
Kyle WangCincinnati$412K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →